Last reviewed · How we verify
Single intravenous injection of Tegileridine Fumarate
Single intravenous injection of Tegileridine Fumarate is a Small molecule drug developed by Second Affiliated Hospital, School of Medicine, Zhejiang University. It is currently FDA-approved.
At a glance
| Generic name | Single intravenous injection of Tegileridine Fumarate |
|---|---|
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Determination of the Effective Dose of a Single Intravenous Dose of Tegileridine Fumarate for Postoperative Analgesia After Orthopedic Surgery: A Up-and-Down Sequential Allocation Study (PHASE4)
- Clinical Study of Equivalent Doses of Oxycodone or Tegileridine on Patients Undergoing Gynecological Laparoscopic Hysterectomy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Single intravenous injection of Tegileridine Fumarate CI brief — competitive landscape report
- Single intravenous injection of Tegileridine Fumarate updates RSS · CI watch RSS
- Second Affiliated Hospital, School of Medicine, Zhejiang University portfolio CI
Frequently asked questions about Single intravenous injection of Tegileridine Fumarate
What is Single intravenous injection of Tegileridine Fumarate?
Single intravenous injection of Tegileridine Fumarate is a Small molecule drug developed by Second Affiliated Hospital, School of Medicine, Zhejiang University.
Who makes Single intravenous injection of Tegileridine Fumarate?
Single intravenous injection of Tegileridine Fumarate is developed and marketed by Second Affiliated Hospital, School of Medicine, Zhejiang University (see full Second Affiliated Hospital, School of Medicine, Zhejiang University pipeline at /company/second-affiliated-hospital-school-of-medicine-zhejiang-university).
What development phase is Single intravenous injection of Tegileridine Fumarate in?
Single intravenous injection of Tegileridine Fumarate is FDA-approved (marketed).